Daval, Bonifacia J.

HRN: 14-80-80  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
CEFTAZIDIME 1GM (VIAL)
02/22/2026
02/28/2026
IV
1g
Q8h
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: